Yahoo! Finance: Top Stories

Ascendis Pharma price target raised to $224 from $215 at Oppenheimer

Jun 14, 2025 - 13:50
 0
Ascendis Pharma price target raised to $224 from $215 at Oppenheimer
Read More

Tags:

Previous Article

Unusual Machines terminates agreement to acquire Aloft

Next Article

America's deepest inflation fears are starting to fade

Related Posts

Few companies feel effective at skill validation, survey shows

Few companies feel effective at skill validation, surve...

May 23, 2025  0

Stock market today: Dow, S&P 500, Nasdaq futures slip as US-China pact fails to thrill, with CPI inflation on deck

Stock market today: Dow, S&P 500, Nasdaq futures slip a...

Jun 11, 2025  0

The dollar could lose its crown as an 'unfortunate truth' forces investors to rethink US assets

The dollar could lose its crown as an 'unfortunate trut...

May 22, 2025  0